Sab Biotherapeutics, Inc.

This study is testing an investigational drug called SAB-142 to see if it can slow down the progression of type 1 diabetes in people recently diagnosed. Researchers want to find out if the drug can help the body preserve its own ability to make insulin, potentially reducing the n…